← back to search

Joon‐Yong Chung

National Institutes of Health · US
🔎 Find collaborators in Molecular Biology · Cell Biology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Molecular Biology · Cell Biology
Research interest
Research interests include Epigenetics and DNA Methylation, Endoplasmic Reticulum Stress and Disease, Molecular Biology Techniques and Applications, and Cancer Cells and Metastasis.
h-index
44
citations
7,963
works
307
NIH funding
primary concept
Medicine
email

Recent publications

Coffee Consumption and Colorectal Cancer Survival: A Dose-Response Meta-analysis by Coffee Type and Disease Stage.
2026cited by 0position: contributordoi
Ablation of glypican-3 enhances radiosensitivity in liver cancer by prolonging G2/M arrest and activating the ATM/CHK2 pathway
2026cited by 0position: contributordoi
Interleukin-13 Receptor Subunit Alpha 2 Induces Chemokine Expression and Macrophage Polarization to Promote Inflammation and Fibrosis
International Journal of Radiation Oncology*Biology*Physics 2025cited by 3position: contributordoi
Loss of E-cadherin Activates EGFR-MEK/ERK Signaling, Promoting Cervical Cancer Progression.
2025cited by 3position: contributordoi
Ebastine-mediated destabilization of E3 ligase MKRN1 protects against metabolic dysfunction-associated steatohepatitis.
2025cited by 3position: contributordoi
Generation of Site-Specifically Labeled Affinity Reagents via Use of a Self-Labeling Single Domain Antibody.
2025cited by 3position: contributordoi
Kindlin-1 promotes gastric cancer cell motility through the Wnt/β-catenin signaling pathway.
2025cited by 3position: contributordoi
Prognostic significance of tertiary lymphoid structures in gastric neuroendocrine carcinoma with association to delta-like ligand 3 and neuroendocrine expressions.
2025cited by 1position: contributordoi
Diagnosis and Treatment Response Monitoring of Liver Cancer Using Glypican-3-Targeted Single-Domain Antibody PET.
2025cited by 0position: contributordoi
Supplementary Figure S7 from Diagnosis and Treatment Response Monitoring of Liver Cancer Using Glypican-3–Targeted Single-Domain Antibody PET
2025cited by 0position: contributordoi
Supplementary Figure S1 from Diagnosis and Treatment Response Monitoring of Liver Cancer Using Glypican-3–Targeted Single-Domain Antibody PET
2025cited by 0position: contributordoi
Supplementary Figure S4 from Diagnosis and Treatment Response Monitoring of Liver Cancer Using Glypican-3–Targeted Single-Domain Antibody PET
2025cited by 0position: contributordoi
Supplementary Figure S2 from Diagnosis and Treatment Response Monitoring of Liver Cancer Using Glypican-3–Targeted Single-Domain Antibody PET
2025cited by 0position: contributordoi
Multimodal Approach for Identification and Validation of Hepatocellular Carcinoma Targets for Radiotheranostics
2025cited by 0position: contributordoi
Supplementary Figure S3 from Diagnosis and Treatment Response Monitoring of Liver Cancer Using Glypican-3–Targeted Single-Domain Antibody PET
2025cited by 0position: contributordoi
Data from Diagnosis and Treatment Response Monitoring of Liver Cancer Using Glypican-3–Targeted Single-Domain Antibody PET
2025cited by 0position: contributordoi
Supplementary Figure S6 from Diagnosis and Treatment Response Monitoring of Liver Cancer Using Glypican-3–Targeted Single-Domain Antibody PET
2025cited by 0position: contributordoi
Supplementary Figure S5 from Diagnosis and Treatment Response Monitoring of Liver Cancer Using Glypican-3–Targeted Single-Domain Antibody PET
2025cited by 0position: contributordoi
Supplementary Table S1 from Diagnosis and Treatment Response Monitoring of Liver Cancer Using Glypican-3–Targeted Single-Domain Antibody PET
2025cited by 0position: contributordoi
CHIP ameliorates nonalcoholic fatty liver disease via promoting K63- and K27-linked STX17 ubiquitination to facilitate autophagosome-lysosome fusion.
2024cited by 11position: contributordoi
Disrupting Notch signaling related HES1 in myeloid cells reinvigorates antitumor T cell responses.
2024cited by 8position: contributordoi
Glypican-3 deficiency in liver cancer upregulates MAPK/ERK pathway but decreases cell proliferation.
2024cited by 6position: contributordoi
Single-Cell Transcriptional Signatures of Glomerular Disease in Transgenic Mice with APOL1 Variants.
2024cited by 2position: contributordoi
Developing a comprehensive molecular subgrouping model for cervical cancer using machine learning.
2024cited by 1position: contributordoi
Disrupting Notch signaling related HES1 in myeloid cells reinvigorates antitumor T cell responses
2024cited by 0position: contributordoi
Author Correction: Ablation of the deubiquitinase USP15 ameliorates nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
2024cited by 0position: contributordoi
Author Correction: CHIP ameliorates nonalcoholic fatty liver disease via promoting K63- and K27-linked STX17 ubiquitination to facilitate autophagosome-lysosome fusion.
2024cited by 0position: contributordoi
Single-Nucleus RNA Sequencing Reveals Loss of Distal Convoluted Tubule 1 Renal Tubules in HIV Viral Protein R Transgenic Mice.
2024cited by 0position: contributordoi
TRPV1 inhibition overcomes cisplatin resistance by blocking autophagy-mediated hyperactivation of EGFR signaling pathway.
2023cited by 38position: contributordoi
Ablation of the deubiquitinase USP15 ameliorates nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
2023cited by 17position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 46 papers (2019–2026)Stephen M. Hewitt · Cancer Institute (WIA)32 papers (2019–2026)Freddy E. Escorcia · National Institutes of Health15 papers (2022–2026)Peter L. Choyke · University Research Co (United States)12 papers (2022–2026)Woonghee Lee · National Institutes of Health12 papers (2025–2026) · 12 papers (2022–2026)Stanley Fayn · National Institutes of Health12 papers (2025–2026)Hima Makala · National Institutes of Health12 papers (2025–2026)Divya Nambiar · National Institutes of Health12 papers (2025–2026)Mitchell Ho · NIHR Clinical Research Network11 papers (2025–2025)Orit Jacobson · National Institutes of Health11 papers (2025–2025)Bradford J. Wood · University of South Alabama11 papers (2022–2025)Falguni Basuli · National Institutes of Health10 papers (2025–2025)Rolf E. Swenson · National Eye Institute10 papers (2025–2025)Robert Morhard · National Institutes of Health Clinical Center10 papers (2025–2025)Ross W. Cheloha · Duke University10 papers (2025–2025)Colleen P. Olkowski · National Institutes of Health10 papers (2025–2025) · 10 papers (2025–2025) · 10 papers (2025–2025)Jianfeng Shi · National Institutes of Health10 papers (2025–2025)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Molecular Biology · Cell Biology →